Market Pathways Scorecard: FDA FY 2025 Trends

article image
ARTICLE SUMMARY:

An infographic marking FDA's performance on device authorizations, inspections, and guidance development during the just-ended fiscal year 2025.

Novel device approvals were relatively even in FY 2025 compared to the past two years, but FDA published notably less device guidance documents during the recent fiscal period. That and more in this month’s Market Pathways Scorecard.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: